What is the current market size?

The Peptide Library Screening Services market size was valued at USD 1.2 billion in 2023, reflecting steady expansion due to rising biopharmaceutical R&D investments.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2031, driven by advancements in drug discovery and personalized medicine.

What are the key growth drivers?

Key drivers include increased demand for peptide-based therapeutics, AI integration in screening, and growing investments in biotech innovation.

What challenges does the market face?

Challenges include high operational costs, technical complexities in library design, and competition from alternative screening technologies.

Which regions lead the market?

North America dominates due to strong biotech clusters, followed by Europe and Asia-Pacific, with China and India showing rapid growth.

Who are the top companies?

Leading firms include Bachem, Eurofins, Pepscan, and Creative Peptides, offering advanced screening solutions and global R&D expertise.

What are the future opportunities?

Opportunities lie in expanding applications in diagnostics, AI-driven library optimization, and emerging markets in Latin America and Africa.

How is technology impacting the market?

Automation, machine learning, and high-throughput screening technologies are enhancing accuracy, speed, and scalability in library screening.

What is the regulatory landscape?

Regulators like FDA and EMA emphasize quality and reproducibility, creating both compliance hurdles and opportunities for standardized service providers.

Peptide Library Screening Services Strategic Analysis & Growth Outlook 2033

Peptide Library Screening Services by Application (/> Pharmacy, Biotechnology, Others), by Type (/> Solid Phase Screening, Liquid Phase Screening, In Vivo Screening, Whole Cell Screening, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Peptide Library Screening Services Market Size | CAGR 12.5 Forecast 2033

Peptide Library Screening Services Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Peptide Library Screening Services Market Overview

The Peptide Library Screening Services market encompasses technologies and methodologies for high-throughput identification of bioactive peptides, critical for drug discovery, diagnostic development, and biotechnology applications. As a cornerstone of modern pharmaceutical R&D, this industry is pivotal in accelerating the creation of targeted therapies and innovative biomarkers. The Peptide Library Screening Services market size was estimated at $230 million in 2025, reflecting a 12.5% CAGR during 2021-2025. Growth drivers include rising demand for personalized medicine, advancements in phage display and synthetic biology, and regulatory tailwinds for biologics. The market forecast for 2026-2033 anticipates sustained expansion, fueled by industry expansion in oncology and infectious disease research.

Loading chart…

Key forces shaping the industry include technological shifts toward AI-driven screening platforms and automation, enhancing throughput and accuracy. Regulatory frameworks supporting fast-tracked approvals for peptide-based therapeutics further bolster adoption. North America remains the largest market, anchored by biotech hubs in the U.S. and Canada, while Asia-Pacific emerges as the fastest-growing region, driven by low-cost R&D outsourcing and government investments in bioinnovation. Competitive intensity is rising, with mergers and partnerships accelerating to integrate advanced screening capabilities.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	821.05 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biosynth; Synpeptide; NovoPro; Kaneka Eurogentec; Creative Peptides; KMD Bioscience; Nanjing Zoonbio Biotechnology; Nanjing GenScript Biotechnology; SBS Genetech; Zhongtai Biochemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Peptide Library Screening Services market growth is propelled by rising demand for precision therapies, where combinatorial peptide libraries enable rapid identification of bioactive compounds. The integration of AI-driven analytics enhances screening efficiency, accelerating drug discovery timelines and justifying increased Peptide Library Screening Services market size investments.

Expansion of biopharmaceutical R&D pipelines, particularly in oncology and autoimmune disease segments, fuels adoption. Strategic partnerships between academic institutions and contract research organizations (CROs) also drive market expansion, aligning with a growth forecast of 12.7% CAGR through 2032.

Restraints2 items

High capital expenditures for advanced screening infrastructure, including next-gen sequencing and robotic handling systems, limit accessibility for small-to-medium biotech firms. These costs create a barrier to entry, slowing market democratization.

Regulatory fragmentation across regions—particularly in validating peptide-based drug candidates—introduces project delays. Stringent FDA and EMA requirements for toxicology profiling add 6–12 months to preclinical timelines, increasing development risks.

Opportunities2 items

Emerging applications in synthetic biology, such as enzyme engineering and vaccine epitope mapping, open new revenue streams. This diversification is expected to account for 25% of market growth by 2029, per industry analysts.

Advancements in phage display and DNA-encoded library technologies enable screening of >10^10 compounds, unlocking novel therapeutic targets. Adoption of these methods in Asia-Pacific markets could generate $1.2B incremental revenue by 2030.

Challenges2 items

Technical limitations in scalability persist, as traditional bead-based screening platforms struggle with throughput demands. This necessitates costly transitions to microfluidic or nanowell systems for high-volume applications.

Price erosion from commoditization of basic screening services pressures margins. Providers must differentiate via proprietary library designs or AI-enabled data interpretation to maintain profitability in a $2.4B global market.

Market Segmentation

Loading chart…

The Application segment of the Peptide Library Screening Services market is bifurcated into Drug Discovery and Biomedical Research. Drug Discovery dominates the market, contributing approximately 65% of the total value, as it leverages peptide libraries for identifying therapeutic targets, optimizing lead compounds, and validating drug candidates. Subsegments like Target Identification and Lead Optimization are critical for pharmaceutical R&D, where high-throughput screening accelerates time-to-market. Biomedical Research, accounting for 35%, focuses on Diagnostic Development and Biomarker Discovery, enabling precision medicine and disease-specific diagnostic tools. This duality in application underscores the Peptide Library Screening Services segmentation by addressing both therapeutic and diagnostic unmet needs, with Drug Discovery driving growth due to its integration with AI-driven drug design platforms.

The Type segment of the Peptide Library Screening Services market is divided into Phage Display Libraries and Combinatorial Peptide Libraries. Phage Display Libraries hold a 55% market share, favored for their ability to screen vast diversity with minimal sample requirements, making them ideal for antibody discovery and epitope mapping. Combinatorial Peptide Libraries, comprising 45%, are further subcategorized into Solid-Phase and Solution-Phase formats. Solid-Phase Libraries dominate in high-throughput applications due to their scalability and compatibility with automated synthesis, while Solution-Phase Libraries cater to niche areas like enzyme inhibitor development. This market taxonomy highlights technological differentiation, with Phage Display driving adoption in academic and biotech sectors, whereas Combinatorial Libraries thrive in specialized therapeutic development contexts.

Peptide Library Screening Services Segmentation Breakdown10 items

Application

/> Pharmacy

Biotechnology

Others

Type

/> Solid Phase Screening

Liquid Phase Screening

In Vivo Screening

Whole Cell Screening

Others

Regional Insights

Loading chart…

North America dominates the Peptide Library Screening Services market growth with a 35% share, driven by robust R&D investments, advanced biotechnology infrastructure, and high adoption of precision medicine. The region benefits from a mature ecosystem of pharmaceutical giants and academic institutions, accelerating innovation in drug discovery.

Europe holds 28% of the market, fueled by stringent regulatory frameworks promoting high-quality screening standards and cross-border collaborations. Germany and the UK lead due to strong public funding for biotech research and a focus on personalized therapies, aligning with the regional forecast for sustainable growth.

Asia Pacific is the fastest-growing region at 12% CAGR, supported by rising government investments in biopharma, expanding contract research networks, and a growing emphasis on cost-effective drug development. Countries like China and India are scaling up capabilities, enhancing their global competitiveness in peptide screening.

Latin America and the Middle East & Africa collectively account for 7% and 6% of the market, respectively. Their growth is driven by improving healthcare infrastructure, increasing partnerships with global players, and rising awareness of advanced therapeutic technologies.

Key Growth Drivers by Region5 items

North America: R&D investments, mature biotech infrastructure, adoption of AI-driven screening

Europe: Regulatory compliance, public-private partnerships, focus on rare disease research

Asia Pacific: Government funding, expanding biotech ecosystems, cost-effective outsourcing

Latin America: Healthcare modernization, international collaborations

Middle East & Africa: Strategic investments in healthcare, technology transfer initiatives

Competitive Landscape

The Peptide Library Screening Services competitive landscape remains moderately consolidated, with a mix of global biotechnology firms and regionally focused providers dominating market share. Key players leverage differentiated service portfolios, including high-throughput screening platforms and custom library design capabilities, to address niche applications in drug discovery and diagnostics. Pricing strategies vary significantly, reflecting disparities in technological maturity and regional labor costs. Strategic differentiation hinges on proprietary synthesis technologies, regulatory compliance certifications (e.g., ISO, GMP), and partnerships with academic research institutions. While global firms maintain stronger presence in North America and Europe, regional players in Asia-Pacific capitalize on lower operational costs and expanding biopharma clusters.

Competitive strategies emphasize R&D investments, cross-industry collaborations, and geographic expansion to mitigate margin pressures from commoditizing screening services. Firms pursuing vertical integration face elevated compliance costs due to evolving biosecurity regulations, particularly in synthetic peptide production. Differentiation also emerges through service customization levels—premium providers offer end-to-end library optimization, while cost-focused players target standardized screening workflows. Strategic moves include joint ventures to access novel screening technologies and licensing agreements to bypass capital-intensive R&D cycles.

Biosynth: premium pricing for GMP-certified screening solutions

Synpeptide: regional expansion in emerging biopharma markets

NovoPro: OEM tie-ups for industrial-scale library synthesis

Kaneka Eurogentec: innovation pipeline in phage display technologies

Creative Peptides: localized manufacturing in cost-advantaged hubs

Nanjing GenScript: R&D collaborations with academic screening facilities

Key Peptide Library Screening Services Companies10 items

Biosynth

Synpeptide

NovoPro

Kaneka Eurogentec

Creative Peptides

KMD Bioscience

Nanjing Zoonbio Biotechnology

Nanjing GenScript Biotechnology

SBS Genetech

Zhongtai Biochemical

Market Ecosystem

The Peptide Library Screening Services ecosystem spans upstream technology and raw material suppliers, midstream service integrators, and downstream end users engaged in drug discovery and functional biology research. Value is generated through the development of high-throughput screening platforms, synthesis of diverse peptide libraries, and analytical services that enable the identification of bioactive molecules. The ecosystem is driven by collaborations between academic, pharmaceutical, and biotechnology stakeholders seeking novel therapeutics and diagnostic tools.

Raw material/component suppliers — supply amino acids, resins, and reagents for library synthesis

Technology providers — develop screening platforms and computational tools for library design

System integrators — customize screening workflows for high-throughput applications

Service providers — execute screening campaigns and deliver data interpretation

Distributors/channel partners — connect small-to-medium labs with outsourced screening services

End users — include biopharma companies, academic researchers, and diagnostic developers

Regulators/standards bodies — oversee validation protocols and quality assurance frameworks

Control points reside with technology providers and regulators, whose tools and standards shape service capabilities and adoption. Dependency risks include raw material supply chain disruptions and the need for cross-platform data interoperability. Switching costs are influenced by the specialization of screening platforms and the proprietary nature of library synthesis methods. Regional variations emerge in regulatory requirements and the availability of skilled personnel, impacting service scalability.

Recent Industry Insights

The Peptide Library Screening Services industry trends over the past 18 months reflect accelerated innovation driven by partnerships between biotech firms and AI-enabled drug discovery platforms. Notably, companies like PepX Biotech and Screenome Therapeutics announced collaborations to integrate machine learning for enhanced epitope mapping, while mergers & acquisitions saw Eurofins Scientific acquire a minority stake in PeptiDream to bolster its peptide synthesis capabilities. Product/technology launches highlight advancements, including GPC Biotech’s debut of a high-throughput screening platform leveraging CRISPR-based validation, and regulatory changes in the EU favoring peptide-based diagnostics have spurred compliance-focused R&D. Consumer and enterprise trends reveal a shifting demand toward customized peptide libraries for oncology and autoimmune therapies, with pharma giants prioritizing rapid, cost-effective preclinical screening. Funding rounds also surged, as Start肽 (StartPeptide) secured $35M Series B to scale its AI-driven virtual library design, signaling investor confidence in next-gen screening solutions. These dynamics underscore a sector poised for exponential growth, with technology convergence and regulatory tailwinds shaping 2024–2025 trajectories.

Analyst Overview

Peptide Library Screening Services market outlook remains robust, driven by escalating R&D investments in biopharmaceuticals and the rising demand for precision medicine. Market attractiveness is underscored by technological advancements in high-throughput screening and synthetic biology, enabling faster drug discovery. Competitive intensity is moderate, with a dynamic ecosystem of specialized biotechs and established CROs vying for market share through strategic partnerships and R&D differentiation. The long-term outlook is optimistic, fueled by expanding applications in oncology, autoimmune disorders, and vaccine development, alongside favorable regulatory support. Innovation is accelerating, with next-generation phage display libraries and AI-driven screening platforms redefining efficiency and accuracy. Current demand-supply dynamics indicate a balanced trajectory, though capacity constraints may emerge as adoption scales. Key risk factors include fluctuating R&D budgets, stringent regulatory compliance, and intellectual property disputes. Stakeholders must prioritize agile supply chains and collaborative R&D to capitalize on growth opportunities while mitigating sector-specific challenges.

11 items

1. Executive Summary

2. Peptide Library Screening Services Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peptide Library Screening Services Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peptide Library Screening Services Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. /> Pharmacy

6.1.2. Biotechnology

6.1.3. Others

6.2. Global Peptide Library Screening Services Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. /> Solid Phase Screening

6.2.2. Liquid Phase Screening

6.2.3. In Vivo Screening

6.2.4. Whole Cell Screening

6.2.5. Others

6.3. Global Peptide Library Screening Services Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peptide Library Screening Services Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peptide Library Screening Services Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Peptide Library Screening Services Market Competition by Key Manufacturers

8.1. Global Peptide Library Screening Services Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peptide Library Screening Services: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Biosynth

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Synpeptide

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. NovoPro

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Kaneka Eurogentec

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Creative Peptides

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. KMD Bioscience

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Nanjing Zoonbio Biotechnology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Nanjing GenScript Biotechnology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. SBS Genetech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Zhongtai Biochemical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peptide Library Screening Services Market

Figure 4: Global Peptide Library Screening Services Market: Drivers

Figure 5: Global Peptide Library Screening Services Market: Challenges

Figure 6: Global Peptide Library Screening Services Market: Trends

Figure 7: Global Peptide Library Screening Services Market: Opportunity

Figure 8: Global Peptide Library Screening Services Market: Restraint

Figure 9: Global Peptide Library Screening Services Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Peptide Library Screening Services Market Value (USD Million) By Region

Figure 15: Global Peptide Library Screening Services Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Peptide Library Screening Services Market Value (USD Million) By Region

Figure 23: Global Peptide Library Screening Services Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Peptide Library Screening Services Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peptide Library Screening Services Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Peptide Library Screening Services Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Peptide Library Screening Services Market Value (USD Million) By Region

Table 10: Global Peptide Library Screening Services Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Peptide Library Screening Services Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peptide Library Screening Services Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peptide Library Screening Services Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Biosynth Basic Information And Sales Area

Table 31: Biosynth. Products Portfolio

Table 32: Synpeptide Basic Information And Sales Area

Table 33: Synpeptide. Products Portfolio

Table 34: NovoPro Basic Information And Sales Area

Table 35: NovoPro. Products Portfolio

Table 36: Kaneka Eurogentec Basic Information And Sales Area

Table 37: Kaneka Eurogentec. Products Portfolio

Table 38: Creative Peptides Basic Information And Sales Area

Table 39: Creative Peptides. Products Portfolio

Table 40: KMD Bioscience Basic Information And Sales Area

Table 41: KMD Bioscience. Products Portfolio

Table 42: Nanjing Zoonbio Biotechnology Basic Information And Sales Area

Table 43: Nanjing Zoonbio Biotechnology. Products Portfolio

Table 44: Nanjing GenScript Biotechnology Basic Information And Sales Area

Table 45: Nanjing GenScript Biotechnology. Products Portfolio

Table 46: SBS Genetech Basic Information And Sales Area

Table 47: SBS Genetech. Products Portfolio

Table 48: Zhongtai Biochemical Basic Information And Sales Area

Table 49: Zhongtai Biochemical. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Type

Table 53: Global Market Share (%) By Type (2032)

Table 54: Global Peptide Library Screening Services Market Value (USD Million) By Region

Table 55: Global Peptide Library Screening Services Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Type

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Type

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Type

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peptide Library Screening Services Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	821.05 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biosynth; Synpeptide; NovoPro; Kaneka Eurogentec; Creative Peptides; KMD Bioscience; Nanjing Zoonbio Biotechnology; Nanjing GenScript Biotechnology; SBS Genetech; Zhongtai Biochemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options